Literature DB >> 29290214

Dietary management of dyslipidaemias. Is there any evidence for cardiovascular benefit?

Panagiotis Anagnostis1, Stavroula A Paschou2, Dimitrios G Goulis3, Vasilios G Athyros4, Asterios Karagiannis4.   

Abstract

Specific dietary strategies are the mainstay of management in most cases of dyslipidaemia, prior to or simultaneously with the initiation of a lipid-lowering agent. The exact approach differs according to the type of dyslipidaemia. In particular, a reduction in carbohydrates (mainly foods with a high glycaemic index) and their substitution with mono- and polyunsaturated fatty acids is the main strategy in patients with high levels of triglycerides (Tg) and/or low levels of high-density lipoprotein cholesterol (HDL-c). A reduction in saturated and trans fatty acids, combined with an increased intake of specific dietary components, such as plant sterols, soy protein and red yeast rice, constitutes the more efficacious dietary approach in cases where levels of total cholesterol and low-density lipoprotein cholesterol (LDL-c) are elevated. A reduction in excessive body weight is beneficial in every type of dyslipidaemia, whereas increased physical activity is mostly effective in cases with low HDL-c and high Tg levels. With respect to the potential cardiovascular benefit of these dietary interventions, there is currently evidence for the Mediterranean diet. Potential benefit may derive also from single dietary components of that diet, such as legumes, fruits, vegetables, nuts and omega-3 fatty acids, although to a lesser extent than with that general dietary pattern. The purpose of this review is to outline current knowledge regarding the recommended specific dietary pattern according to the type of dyslipidaemia and the evidence for the potential cardiovascular benefits of such approaches.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dyslipidaemia; Hypercholesterolaemia; Hypertriglyceridaemia; Mediterranean diet; Red yeast rice; Sterols

Mesh:

Year:  2017        PMID: 29290214     DOI: 10.1016/j.maturitas.2017.11.011

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  5 in total

Review 1.  Nuts and Cardiovascular Disease Prevention.

Authors:  A M Coates; A M Hill; S Y Tan
Journal:  Curr Atheroscler Rep       Date:  2018-08-09       Impact factor: 5.113

2.  An autophagy-related lncRNA prognostic risk model for thyroid cancer.

Authors:  Yanan Shan; Ran He; Xiaowei Yang; Siwen Zang; Shan Yao; Min Gao; Sixuan Li; Zhihua Yin
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-11-01       Impact factor: 2.503

3.  Changes in Serum, Red Blood Cell, and Colonic Fatty Acids in a Personalized Omega-3 Fatty Acid Supplementation Trial.

Authors:  Yifan Shen; Ananda Sen; D Kim Turgeon; Jianwei Ren; Gillian Graifman; Mack T Ruffin; William L Smith; Dean E Brenner; Zora Djuric
Journal:  Nutr Cancer       Date:  2021-03-24       Impact factor: 2.816

4.  Classification of the Occurrence of Dyslipidemia Based on Gut Bacteria Related to Barley Intake.

Authors:  Satoko Maruyama; Tsubasa Matsuoka; Koji Hosomi; Jonguk Park; Mao Nishimura; Haruka Murakami; Kana Konishi; Motohiko Miyachi; Hitoshi Kawashima; Kenji Mizuguchi; Toshiki Kobayashi; Tadao Ooka; Zentaro Yamagata; Jun Kunisawa
Journal:  Front Nutr       Date:  2022-03-24

Review 5.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.